Hopman Mark sold BBNX
September 9, 2026 · Form 4 insider transaction
Hopman Mark sold 35,994 shares of Beta Bionics, Inc. at $18.46 per share, a transaction worth $664.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 9 days after the transaction.
Direction
Disposed (sell-side)
Shares
35,994
Price
$18.46
Total value
$664.6K
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 9, 2026
Filing dateSeptember 18, 2026
Shares owned after88,033
OwnershipDirect
10b5-1 planYes
AmendedYes
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026 (the "10b5-1 Plan").; On September 10, 2026, the reporting person filed a Form 4 which incorrectly reported the number of shares disposed. The reporting person sold 35,994 shares under the 10b5-1 Plan on September 9, 2026 and the number of securities beneficially owned following the sale was 88,033 shares.